Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 3Recruiting 2

Sponsor Class

OTHER 3

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Lymphoid 5Other hematologic neoplasm 4Plasma cell 3CNS 3Myeloid 2Gastrointestinal 2Sarcoma 1Genitourinary 1Dermatologic 1Classical hematology 1Breast 1

Conditions

Central Nervous System Neoplasms 2Oligodendroglioma 1Glioma 1Astrocytoma 1

Interventions

Temozolomide 299Radiotherapy 219Bevacizumab 139Carboplatin 91Cyclophosphamide 88Etoposide 82Filgrastim 72Vincristine 69Irinotecan 69Magnetic Resonance Spectroscopy 65Cisplatin 59Radiation 58Radiosurgery 52Surgical Procedures, Operative 41Peripheral Blood Stem Cell Transplantation 40Topotecan 39Doxorubicin 39Lomustine 37Carmustine 36sargramostim 35Granulocyte Colony-Stimulating Factor 35Melphalan 34Nivolumab 32Chemotherapy, Adjuvant 32Radiotherapy, Intensity-Modulated 29Isotretinoin 29Everolimus 29Erlotinib Hydrochloride 27Thiotepa 25Vorinostat 24

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Influenza Vaccines × CNS × Clear all
NCT02747407 2021-10-29

Qualitative, Qualitative, and Functional Studies Over the First Year in Measuring Immune System Response During the First Year of Therapy in Patients With Brain Tumors

Wake Forest University Health Sciences

Completed
55 enrolled
CNS

Astrocytoma, Glioma, Oligodendroglioma

NCT01941758 2018-07-05

High-Dose Trivalent Influenza Vaccine in Inducing Immune Response Patients With Central Nervous System Tumors

Wake Forest University Health Sciences

Phase 1 Completed
28 enrolled
CNS

Central Nervous System Neoplasms

NCT01474174 2018-07-03

Trivalent Influenza Vaccine in Preventing Flu in Patients With Central Nervous System Tumors

Wake Forest University Health Sciences

Completed
38 enrolled
CNS

Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡